Skip to main content

To Our Valued Patients,

With the evolving situation of the Coronavirus (COVID-19) pandemic, effective immediately, we will be suspending all non-urgent eye care. Moreover, any non-emergent or elective surgery will also have to be postponed. We will continue to remain open for patients with urgent and emergent concerns only. It is important to us to keep these patients out of the emergency room so our healthcare heroes on the front lines can be available for the patients that need them the most.

Our staff will continue to answer calls and scheduling appointments to the best of their ability.  In addition, if appropriate, Dr Patel can be available for telemedicine visits via online video chat. If you would like to schedule a telemedicine appointment with Dr. Patel, please call our office first to determine eligibility and to obtain an appointment time. Instructions for how to connect to the telemedicine appointment will be given at that time.

We hope to see you back in our office in the not too distant future. Stay safe and stay healthy!

The Turner Eye Institute Team

Book Exam
Call Us

With offices in San Leandro, Concord
and Castro Valley

Home » What's New » Link between Flomax use and Cataract Intraoperative Complications

Link between Flomax use and Cataract Intraoperative Complications

Flomax and cataract surgery (San Francisco, Oakland, Concord, San Jose, and Bay Area)

The U.S. Food and Drug Administration (FDA) is warning healthcare professionals (particularly cataract surgeons) regarding the risk for intraoperative floppy iris syndrome (IFIS) during cataract surgery in patients treated with tamsulosin HCl (Flomax capsules) or other alpha-1 blockers.

Male patients considering cataract surgery should be checked for use of Flomax or Alpha-1 blockers as part of their medical history, according to an alert sent yesterday from MedWatch, the FDA’s safety information and adverse event reporting system.

Although most cases of IFIS have been linked to use of alpha-1 blockers during surgery, some occurred after recent discontinuation of therapy (2 to 14 days), and a few were reported 5 weeks to 9 months after the drug had been stopped.

IFIS is a small pupil syndrome variant that is characterized by a flaccid iris that billows in response to intraoperative irrigation, progressive intraoperative miosis despite preoperative use of mydriatic drugs, and potential prolapse of the iris toward the phacoemulsification incisions.

Ophthalmologists (particularly cataract surgeons) should be prepared to minimize the consequences of IFIS through surgical techniques including use of iris hooks, iris dilator rings, or viscoelastic devices such as Healon 5.

The FDA notes that the benefit of stopping Flomax or alpha-1 blocker therapy prior to cataract surgery has not been established.

Tamsulosin (known as Flomax) is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.